MIT Holding, Inc. (MITD) Offers Patients an Opportunity to Relax in Style
With advancements in medicine, technology and quality of life, people are, on average, living much longer these days than they ever have before. In an effort to further improve quality of life for its patients, MIT Holding, Inc. (OTCQB: MITD) partners with hospitals, physicians, facility based providers, pharmaceutical manufacturers and healthcare payers, through its portfolio of services, to provide post-acute care to patients nationwide. In addition to educational programs and in-home treatment options, the company offers unique travel ventures designed to dramatically improve its patients’ quality of life without creating unnecessary medical risk.
The MIT Holding’s Medical Sea Cruises program will offer individuals who require dialysis or infusion treatment the opportunity to travel abroad with family and friends without missing out on required medical care. The company’s commitment to the care of its patients is the foundation for its unique travel options. With dedicated and trained medical professionals readily available throughout their vacation, patients can relax in style without unnecessary fear of health-related complications.
The company’s travel programs open the door for thousands of patients whose travel may have been highly restricted in the past. According to reports from the Centers for Disease Control and Prevention, an estimated 29.1 million people, or 9.3% of the U.S. population, struggle with diabetes, which accounts for just over 38% of kidney failure cases throughout the country. As a result, nearly 230,000 people of all ages live on chronic dialysis, which can seriously restrict the opportunity for prolonged travel.
The company’s mission is to be the leader in medical and technological innovations created to enhance the physical, emotional and aesthetic quality of life of its patients. While MIT Holding continues to serve its patients throughout Georgia and South Carolina with high quality ambulatory care and home infusion services, few programs can compare to the potential to enhance the overall freedom and quality of life of patients presented by the company’s Medical Sea Cruises program.
For more information on MIT Holding, visit www.mitholdinginc.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
With advancements in medicine, technology and quality of life, people are, on average, living much longer these days than they ever have before. In an effort to further improve quality of life for its patients, MIT Holding, Inc. (OTCQB: MITD) partners with hospitals, physicians, facility based providers, pharmaceutical manufacturers and healthcare payers, through its portfolio of services, to provide post-acute care to patients nationwide. In addition to educational programs and in-home treatment options, the company offers unique travel ventures designed to dramatically improve its patients’ quality of life without creating unnecessary medical risk.
The MIT Holding’s Medical Sea Cruises program will offer individuals who require dialysis or infusion treatment the opportunity to travel abroad with family and friends without missing out on required medical care. The company’s commitment to the care of its patients is the foundation for its unique travel options. With dedicated and trained medical professionals readily available throughout their vacation, patients can relax in style without unnecessary fear of health-related complications.
The company’s travel programs open the door for thousands of patients whose travel may have been highly restricted in the past. According to reports from the Centers for Disease Control and Prevention, an estimated 29.1 million people, or 9.3% of the U.S. population, struggle with diabetes, which accounts for just over 38% of kidney failure cases throughout the country. As a result, nearly 230,000 people of all ages live on chronic dialysis, which can seriously restrict the opportunity for prolonged travel.
The company’s mission is to be the leader in medical and technological innovations created to enhance the physical, emotional and aesthetic quality of life of its patients. While MIT Holding continues to serve its patients throughout Georgia and South Carolina with high quality ambulatory care and home infusion services, few programs can compare to the potential to enhance the overall freedom and quality of life of patients presented by the company’s Medical Sea Cruises program.
For more information on MIT Holding, visit www.mitholdinginc.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
